SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-19-004353
Filing Date
2019-03-07
Accepted
2019-03-07 17:25:24
Documents
102
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K acrx20181231_10k.htm 10-K 2162301
2 EXHIBIT 10.18 ex_136829.htm EX-10.18 10233
3 EXHIBIT 10.44 ex_136830.htm EX-10.44 399827
4 EXHIBIT 21.2 ex_136504.htm EX-21.2 1519
5 EXHIBIT 23.1 ex_136505.htm EX-23.1 5889
6 EXHIBIT 31.1 ex_136506.htm EX-31.1 9291
7 EXHIBIT 31.2 ex_136507.htm EX-31.2 9475
8 EXHIBIT 32.1 ex_136508.htm EX-32.1 7168
15 b1.jpg GRAPHIC 8190
16 a2.jpg GRAPHIC 27743
17 a1.jpg GRAPHIC 32214
  Complete submission text file 0001437749-19-004353.txt   9472780

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT acrx-20181231.xml EX-101.INS 1800411
10 XBRL TAXONOMY EXTENSION SCHEMA acrx-20181231.xsd EX-101.SCH 95903
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acrx-20181231_cal.xml EX-101.CAL 57558
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20181231_def.xml EX-101.DEF 576118
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20181231_lab.xml EX-101.LAB 498948
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20181231_pre.xml EX-101.PRE 617034
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35068 | Film No.: 19666820
SIC: 2834 Pharmaceutical Preparations